Literature DB >> 19524571

Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1.

Mei Jiang1, Yankun Gao, Tao Yang, Xueliang Zhu, Jiangye Chen.   

Abstract

A novel cyclin, CCNY, was identified as a PFTK1 interacting protein in a yeast two-hybrid screen. The cyclin box in CCNY and the PFTAIRE motif in PFTK1 are both required for the interaction which was confirmed by in vivo and in vitro assays. Two transcripts (4 and 2kb), of CCNY were detected by Northern blot analysis and CCNY was enriched at the plasma membrane due to an N-terminal myristoylation signal. We propose that binding of CCNY to PFTK1 enhances PFTK1 kinase activity and changes its intracellular location.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524571     DOI: 10.1016/j.febslet.2009.06.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

1.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

2.  CDK14 Contributes to Reactive Gliosis via Interaction with Cyclin Y in Rat Model of Spinal Cord Injury.

Authors:  Chengwei Duan; Yonghua Liu; Lu Lu; Rixin Cai; Huaqing Xue; Xingxing Mao; Chen Chen; Rong Qian; Dongmei Zhang; Aiguo Shen
Journal:  J Mol Neurosci       Date:  2015-08-28       Impact factor: 3.444

3.  Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers.

Authors:  Wilson K C Leung; Arthur K K Ching; Nathalie Wong
Journal:  Mol Cell Biochem       Date:  2010-12-24       Impact factor: 3.396

4.  Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.

Authors:  Fleur M Ferguson; Zainab M Doctor; Scott B Ficarro; Christopher M Browne; Jarrod A Marto; Jared L Johnson; Tomer M Yaron; Lewis C Cantley; Nam Doo Kim; Taebo Sim; Matthew J Berberich; Marian Kalocsay; Peter K Sorger; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

Review 5.  WNTs in synapse formation and neuronal circuitry.

Authors:  Mikyoung Park; Kang Shen
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

6.  Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.

Authors:  Xiaoling Gu; Yingying Wang; Hua Wang; Qichao Ni; Chunhui Zhang; Jia Zhu; Wei Huang; Pan Xu; Guoxin Mao; Shuyun Yang
Journal:  Med Oncol       Date:  2015-06-02       Impact factor: 3.064

Review 7.  Regulation of Lrp6 phosphorylation.

Authors:  Christof Niehrs; Jinlong Shen
Journal:  Cell Mol Life Sci       Date:  2010-03-14       Impact factor: 9.261

8.  Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.

Authors:  Xing Liu; Shu-Jian Cui; Shi-Jun Zhu; De-Chun Geng; Long Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Activation/Proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation.

Authors:  Xin Wang; Yingying Jia; Cong Fei; Xiaomin Song; Lin Li
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

Review 10.  CDK inhibitors in cancer therapy, an overview of recent development.

Authors:  Mengna Zhang; Lingxian Zhang; Ruoxuan Hei; Xiao Li; Haonan Cai; Xuan Wu; Qiping Zheng; Cheguo Cai
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.